Patent · US Active

Piperazine compounds

US7612061B2 · kind B2 · utility

0Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 10, 2008
Grant dateNov 3, 2009
Priority date—
Expiry dateNov 10, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound selected from those of formula (I):wherein: Medical products containing the same which are useful in the treatment of conditions requiring a serotonin reuptake inhibitor and/or NK1 antagonist.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.